Long lasting intravitreal drugs: Faricimab and Aflibercept 8 mg

Jean-François Korobelnik, MD, PhD

OTX-TKI Axitinib: Intravitreal Hydrogel Implant

Paolo Lanzetta, MD

Beyond Complement Inhibition: Innovative Strategies for Targeting Geographic Atrophy

Stela Vujosevic, MD, PhD

Oral Drug Pipeline for Retinal Conditions

Valentina Sarao, MD

The Suprachoroidal Route

Daniele Veritti, MD

RNA-based Therapeutics for Retinal Diseases

Bart Leroy, MD, PhD